David Nace
PITTSBURGH — Elderly residents of long-term care facilities mount a detectable antibody response to COVID-19 vaccination, according to a recently conducted survey of UPMC Senior Community residents.
Because it’s not yet known how long the antibodies persist, the authors’ urged continual monitoring for COVID-19 symptoms and cautioned that there’s still a need for controlled reopening of the facilities.
In order to share vital information and guide safe, timely reopening of long-term care facilities, UPMC and University of Pittsburgh School of Medicine clinician-scientists are publishing the findings in medRxiv, a preprint journal, ahead of peer-reviewed publication and announced the results today.